Fewer Warning Letters: Does Change Point To FDA Advancement Or Decline?
This article was originally published in The Pink Sheet Daily
Executive Summary
“Voluntary compliance” by drug firms is resulting in fewer CDER warning letters, FDAer states; House Government Reform Committee investigates a “decline” in enforcement activity by the agency since 2000.
You may also be interested in...
Blame China? Experts Advise Congress, Industry Take A Wider View
The global scope of food safety is becoming apparent, and recent problems with products imported from China are but a part of U.S. food safety concerns, industry experts say
Blame China? Experts Advise Congress, Industry Take A Wider View
The global scope of food safety is becoming apparent, and recent problems with products imported from China are but a part of U.S. food safety concerns, industry experts say
FDA Tackles Observational Studies In Draft Health Claims Guidance
"Scientific conclusions from observational studies cannot be drawn about a relationship between a food component and a disease," FDA concludes in draft guidance for health claim petitioners